MONTEFIORE MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.montefiore.org
Greater Occipital Nerve Block Versus Metoclopramide
Phase 4
Completed
- Conditions
- Migraine
- Interventions
- Procedure: Greater occipital nerve block with bupivacaine
- First Posted Date
- 2017-08-31
- Last Posted Date
- 2021-09-22
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 99
- Registration Number
- NCT03269435
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
A Comparison of Dexmedetomidine Versus Propofol for Use in Intravenous Sedation
Phase 4
Completed
- Conditions
- Anesthesia
- Interventions
- First Posted Date
- 2017-08-21
- Last Posted Date
- 2020-05-13
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 144
- Registration Number
- NCT03255824
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
HCV Group Evaluation and Treatment Uptake (HCV GET-UP) Intervention
Not Applicable
Completed
- Conditions
- Hepatitis CSubstance Use Disorders
- Interventions
- Behavioral: HCV GET-Up (Group Evaluation and Treatment Uptake)
- First Posted Date
- 2017-08-08
- Last Posted Date
- 2021-03-23
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 96
- Registration Number
- NCT03242655
- Locations
- 🇺🇸
Comprehensive Health Care Center, Bronx, New York, United States
Peer Outreach and Navigation Intervention to Increase PrEP Uptake Among Women at High Risk for HIV
Not Applicable
Completed
- Conditions
- Pre-exposure ProphylaxisHIV-1-infection
- Interventions
- Behavioral: Peer Navigation
- First Posted Date
- 2017-07-24
- Last Posted Date
- 2018-07-16
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 66
- Registration Number
- NCT03226873
- Locations
- 🇺🇸
New York Harm Reduction Educators, New York, New York, United States
Metoclopramide for Post Traumatic Headache
Phase 3
Completed
- Conditions
- Post-Traumatic Headache
- Interventions
- First Posted Date
- 2017-07-18
- Last Posted Date
- 2021-11-09
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 160
- Registration Number
- NCT03220958
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
Social Media Based Peer-Led Intervention for HIV Prevention
Not Applicable
Completed
- Conditions
- HIV PreventionPrEP Uptake
- Interventions
- Behavioral: BxNow - General Health CampaignBehavioral: E-PrEP- Peer-Led Intervention about PrEP
- First Posted Date
- 2017-07-11
- Last Posted Date
- 2019-11-06
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 152
- Registration Number
- NCT03213366
- Locations
- 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States
Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
Phase 2
Recruiting
- Conditions
- Autism Spectrum Disorder
- Interventions
- Drug: Matched Placebo
- First Posted Date
- 2017-06-28
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT03202303
- Locations
- 🇺🇸
New York University (NYU) Langone, New York, New York, United States
🇺🇸Montefiore Medical Center, Bronx, New York, United States
Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis
Phase 4
Withdrawn
- Conditions
- Ascites HepaticLiver Cirrhosis
- Interventions
- Biological: Fresh Frozen Plasma (FFP)Biological: Albumin
- First Posted Date
- 2017-06-28
- Last Posted Date
- 2019-06-14
- Lead Sponsor
- Montefiore Medical Center
- Registration Number
- NCT03202524
Sildenafil To Prevent Clot
Early Phase 1
Completed
- Conditions
- ThrombosisHemolysis
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2017-06-27
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT03199612
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome
Phase 2
Completed
- Conditions
- Prader-Willi SyndromeHyperphagia
- Interventions
- Drug: Matched Placebo
- First Posted Date
- 2017-06-23
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Eric Hollander
- Target Recruit Count
- 32
- Registration Number
- NCT03197662
- Locations
- 🇺🇸
Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, United States
© Copyright 2025. All Rights Reserved by MedPath